| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Aug―13 |
Epidemiological and clinical laboratory features of COVID-19 in adults in the Ulyanovsk region |
A Khasanova, A Kafarova |
| 2 |
[GO] |
2025―Mrz―15 |
Comprehensive evaluation of immunological activity of recombinant AD26 and AD5 expressing S protein gene of the SARS-COV-2 virus |
O Zubkova, T Ozharovskaia, O Popova, D Voronina, D Zrelkin, A Tukhvatulin, et al. (+5) A Dzharullaeva, I Dolzhikova, D Shcheblyakov, D Logunov, A Gintsburg |
| 3 |
[GO] |
2025―Mrz―15 |
Clinical and laboratory characteristics of patients with false positive IgM test for SARS-CoV-2 |
S Pylaeva, R Sayfullin, L Karan, O Stukolova, L Kozlovskay, D Sinyavkin, A Ishmukhametov |
| 4 |
[GO] |
2025―Jan―17 |
A comparative study of clinical and laboratory features of COVID-19 in children aged 0-14 years old |
M Pavlova, T Tomov, P Velikov, J Getsova, R Yordanova, N Kapintseva, et al. (+7) M Popov, Y Akcentieva, A Velinova, I Ivanov, V Tolchkov, N Korsun, V Velev |
| 5 |
[GO] |
2024―Sep―15 |
Features of clinical and laboratory manifestations of moderate-to-severe COVID-19 in male and female inpatients |
E Paplauskaya, V Kindaleva, E Kulaha, A Rouba, J Silizevich, A Paplauski |
| 6 |
[GO] |
2024―Sep―15 |
The role of cytokine gene polymorphic variants in predicting COVID-19 outcomes |
N Baranova, L Aschina, A Bolgova, O Lesina |
| 7 |
[GO] |
2024―Jun―02 |
Immunological and biochemical markers of adverse disease outcomes in COVID-19 and chronic heart failure |
A Mordyk, N Bagisheva, M Moiseeva, V Streltsova, E Antipova |
| 8 |
[GO] |
2024―Feb―25 |
Dynamics of platelet-leukocyte aggregates in patients with coronavirus infection, depending on the duration and severity of the disease |
Burdienko |
| 9 |
[GO] |
2024―Jan―23 |
Indicators of lipid peroxidation of biological membranes in patients with COVID-19 |
A Marzhokhova, A Ploskireva, Zh Ponezheva, Z Kharaeva, M Marzhokhova, L Balagova, M Nagoeva |
| 10 |
[GO] |
2024―Jan―23 |
Peculiarities of immune response in patients with COVID-19 |
N Baranova, L Aschina, A Bolgova |
| 11 |
[GO] |
2024―Jan―23 |
Quantitative and qualitative composition of the main populations of lymphocytes in patients with community-acquired pneumonia during the COVID-19 pandemic |
Ivanova |
| 12 |
[GO] |
2023―Sep―15 |
Dynamics of liver function indicators in patients with COVID-19 |
G Yupatov, V Pryshchepenko, V Okulich, N Denisenko |
| 13 |
[GO] |
2023―Sep―15 |
Cytokine profile and anti-inflammatory activity of COVID-19 convalescent plasma in vitro |
A Maksimovich, M Potapnev, I Dunayev, L Gushina, F Karpenko |
| 14 |
[GO] |
2023―Sep―15 |
Neutrophil functional activity indices as predictors of COVID-19 severity |
L Aschina, N Baranova, A Bolgova |
| 15 |
[GO] |
2023―Mai―31 |
Long-term data of interval hypoxic therapy in patient rehabilitation after COVID-19 |
I Misirova, S Startseva, I Borukaeva, Z Abazova, L Kardanova |
| 16 |
[GO] |
2023―Mai―31 |
Peculiarities of management of renal transplant recipients with COVID-19: a clinical case report |
V Zemko, V Okulich, A Dzyadzko |
| 17 |
[GO] |
2023―Mrz―22 |
Comprehensive assessment and diagnostic value of the parameters of the immune system associated with susceptibility and resistance to COVID-19 |
I Shchurok |
| 18 |
[GO] |
2022―Aug―31 |
Predicting the severity of COVID-19 |
O. Chernokov, I. Shchurok |
| 19 |
[GO] |
2022―Aug―31 |
COVID-19 and mucormycosis |
A. Lipnitsky, N. Polovets, R. Surkova, A. Murugova, A. Toporkov, D. Victorov |
| 20 |
[GO] |
2022―Aug―31 |
COVID-19 associated invasive mycoses |
O. Kutsevalova, A. Antonets, V. Krylov, N. Nifantiev, D. Miroshnichenko, A. Mikutin |
| 21 |
[GO] |
2022―Aug―31 |
Allergic rhinitis as a comorbid disease with Covid-19 infection |
I. Shchurok, Y. Derkach |
| 22 |
[GO] |
2022―Aug―31 |
Clinical and epidemiological features of the spread of novel coronavirus infection in the children of Chelyabinsk during the first 12 months of the pandemic |
D. Vasilkova, O. Abramovskikh, A. Pishchalnikov |
| 23 |
[GO] |
2022―Aug―31 |
PostCovid syndrome during the Covid-19 pandemic |
O. Chernokov, I. Shchurok |
| 24 |
[GO] |
2022―Aug―31 |
Pandemic of vitamin D deficiency |
V. Albanova |
| 25 |
[GO] |
2021―Sep―22 |
The relationship of the level of β-defensin-1 in the saliva of patients with oral candidiasis after CoVID-19 infection |
A. Pozharitskaya, I. Karpuk |
| 26 |
[GO] |
2021―Sep―22 |
Chronic obstructive pulmonary disease and smoking in COVID-19. |
A. Ishchenko |
| 27 |
[GO] |
2021―Jun―03 |
Experience of using tocilizumab in the research unit of infectious hospital for patients with coronavirus infection (CoVID-19) |
M Petrushin, V Leontyeva, A Malygin, M Demidova |
| 28 |
[GO] |
2021―Jun―03 |
Long-term follow up of the course of Covid-19 infection in a patient with allergic rhinitis and conjunctivitis |
E Matsko |
| 29 |
[GO] |
2020―Okt―29 |
COVID-19 and complement system: a window of opportunities |
I Vorontsova |
